Westaim Corp. (The)

NUCRYST Announces Special Meeting of Shareholders.
Biotech Week; 12/9/2009; 714 words; ...dated November 10, 2009 among the NUCRYST Pharmaceuticals Corp., NUCRYST Pharmaceuticals...also Nucryst Pharmaceuticals Corp.). If the first special resolution is...wholly-owned subsidiary of The Westaim Corporation substantially on...

NUCRYST announces 2009 third quarter financial results.(Financial report)
Biotech Week; 12/2/2009; 1092 words; ...NUCRYST Pharmaceuticals Corp., a developer and manufacturer...financial results for the third quarter of 2009...Nucryst Pharmaceuticals Corp.). For the quarter ended September...amalgamation agreement with The Westaim Corporation ("Westaim...

Westaim announces 2009 third quarter results.(Financial report)
Biotech Week; 12/2/2009; 893 words; ...Pharmaceuticals Corp., was $24.2 million. Westaim recently announced the execution of an...Pharmaceuticals Corp. (NASDAQ: NCST...Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS). Westaim's common shares are listed on The Toronto Stock...

FORM 8-K: NUCRYST PHARMACEUTICALS ANNOUNCES FINANCIAL STATEMENTS, EXHIBITS
US Fed News Service, Including US State News; 11/26/2009; 530 words; ...terms provided for in the asset purchase agreement...November 10, 2009 among the NUCRYST Pharmaceuticals Corp., NUCRYST Pharmaceuticals...Overseas) Limited. If the first special resolution...owned subsidiary of The Westaim Corporation substantially...

NUCRYST Announces Agreement to Sell Acticoat Business and Proposes Amalgamation with Westaim.
Biotech Week; 11/25/2009; 1192 words; ...Transaction"). The closing of the Sale Transaction is subject...customary conditions including the approval of Nucryst shareholders...Nucryst Pharmaceuticals Corp.). Nucryst also entered...amalgamation agreement with The Westaim Corporation, which currently...